Tenormin

   
Google
 
Web NewDrugInformation.com

Tenormin


Drug - Tenormin
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Atenolol
Multiple ingredients are in alphabetical order.

Strength - 25MG
The potency of the active ingredient(s), Atenolol. May repeat for multiple part products.

Applicant - ASTRAZENECA
The firm name holding legal responsibility for Tenormin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018240
The FDA assigned number to Tenormin. Format is nnnnnn.

Product Number - 004
The FDA assigned number to identify Tenormin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Apr 9, 1990
The date Tenormin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Tenormin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Tenormin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Astrazeneca Lp
The full name of the firm holding legal responsibility for the new application of Tenormin.

Tenormin